Last reviewed · How we verify
YN001, Rosuvastatin calcium Tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
YN001, Rosuvastatin calcium Tablets (YN001, Rosuvastatin calcium Tablets) — Beijing Inno Medicine Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| YN001, Rosuvastatin calcium Tablets TARGET | YN001, Rosuvastatin calcium Tablets | Beijing Inno Medicine Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- YN001, Rosuvastatin calcium Tablets CI watch — RSS
- YN001, Rosuvastatin calcium Tablets CI watch — Atom
- YN001, Rosuvastatin calcium Tablets CI watch — JSON
- YN001, Rosuvastatin calcium Tablets alone — RSS
Cite this brief
Drug Landscape (2026). YN001, Rosuvastatin calcium Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/yn001-rosuvastatin-calcium-tablets. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab